- Home
- BMR vs PEPG Comparison
BMR vs PEPG Comparison
Compare BMR & PEPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMR
- PEPG
- Stock Information
- Founded
- BMR 2009
- PEPG 2018
- Country
- BMR Israel
- PEPG United States
- Employees
- BMR N/A
- PEPG N/A
- Industry
- BMR Computer Software: Prepackaged Software
- PEPG Biotechnology: Pharmaceutical Preparations
- Sector
- BMR Technology
- PEPG Health Care
- Exchange
- BMR Nasdaq
- PEPG Nasdaq
- Market Cap
- BMR 41.9M
- PEPG 45.9M
- IPO Year
- BMR 2023
- PEPG 2022
- Fundamental
- Price
- BMR $2.97
- PEPG $1.99
- Analyst Decision
- BMR
- PEPG Buy
- Analyst Count
- BMR 0
- PEPG 4
- Target Price
- BMR N/A
- PEPG $7.25
- AVG Volume (30 Days)
- BMR 875.5K
- PEPG 539.9K
- Earning Date
- BMR 08-13-2025
- PEPG 11-06-2025
- Dividend Yield
- BMR N/A
- PEPG N/A
- EPS Growth
- BMR N/A
- PEPG N/A
- EPS
- BMR N/A
- PEPG N/A
- Revenue
- BMR $3,131,000.00
- PEPG N/A
- Revenue This Year
- BMR $21.21
- PEPG N/A
- Revenue Next Year
- BMR N/A
- PEPG N/A
- P/E Ratio
- BMR N/A
- PEPG N/A
- Revenue Growth
- BMR 5.96
- PEPG N/A
- 52 Week Low
- BMR $1.86
- PEPG $0.88
- 52 Week High
- BMR $6.59
- PEPG $10.06
- Technical
- Relative Strength Index (RSI)
- BMR 52.21
- PEPG 73.74
- Support Level
- BMR $2.78
- PEPG $1.35
- Resistance Level
- BMR $2.98
- PEPG $2.10
- Average True Range (ATR)
- BMR 0.15
- PEPG 0.18
- MACD
- BMR 0.02
- PEPG 0.07
- Stochastic Oscillator
- BMR 87.82
- PEPG 86.08
About BMR Beamr Imaging Ltd.
Beamr Imaging Ltd is a video technology and image science software company. It is an innovator of video encoding, transcoding, and optimization solutions that enable high quality, performance, and unmatched bitrate efficiency for video and images. The company is conducted through one operating segment, the optimization technology for video and photo compression. The company operates in Israel, the United States, and the rest of the world, it derives a majority of its revenue from the United States.
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.